80021653: 16th Update on the Treatment of Alzheimer's and Related Disorders: Defining the Standard of Care

Click here for a text version of the brochure
Text version of brochure

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nursing Credit
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This 6.5 contact hour Educational Activity is provided by The Institute for Johns Hopkins Nursing.
The Institute for Johns Hopkins Nursing is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners: AANP Provider Number 061216.
This program has been granted 6.5 contact hours of continuing education (which includes pending hours of pharmacology hours).
OTHER CREDIT
This activity has been reviewed and is acceptable for up to 6.50 prescribed credits by the American Academy of Family Physicians.
This CME activity is endorsed by the American Geriatrics Society. Credits earned from this activity may be counted toward the AGS Geriatrics Recognition Award. The Johns Hopkins University has approved this activity for 7.0 contact hours for non-physicians.
The Johns Hopkins University School of Medicine is authorized by the State Board of Examiners of Psychologists as a provider of continuing education. The Johns Hopkins University School of Medicine maintains responsibility for this program. A certificate for 7.0 CEUs will be awarded upon completion of this activity. The Maryland Board of Social Work Examiners certifies that this program meets the criteria for 7.0 credit hours of Category 1 or 7.0 CEUs of continuing education for social workers and associates licensed in Maryland. This CE Program has been approved by the Maryland Board of Professional Counselors and Therapists for Category A.

Description:
This annual activity is designed to provide an update of state-of-the-art, practical approaches to the care of patients with dementia and Alzheimer?s disease, and their caregivers, for all groups of health care professionals. This year?s activity will focus on emerging technologies and their application to the practice of dementia care. There has been unprecedented growth in the development of novel biomarkers beginning to detect and quantify the several biological signatures of the Alzheimer?s brain disease, such as brain amyloid and tau protein. Genetic, brain imaging, protein-based and lipid-based tests are actively being used in research and are slowly being introduced to clinical care. Clinicians involved in dementia care are now faced with learning about and understanding the clinical utility of many new tests of various types. In addition, the recent publication of new treatment guidelines for Alzheimer?s and related dementias by the American Psychiatric Association is being integrated into dementia care practices. The morning session of the activity will review several emerging biomarker technologies that will impact dementia care and the potential applications in the diagnosis, prognosis or treatment monitoring of dementia and its prodromal states, such as Mild Cognitive Impairment-MCI. This will be followed by an expert panel discussion on the issues involved in applying these technologies in the pre-symptomatic diagnosis of people at risk, such as the children of people with dementia.

Objectives:
After attending this activity, the participant will demonstrate the ability to:
- Discuss in detail the several emerging biomarker methodologies that will impact dementia care, such as genetic testing, brain imaging, and analysis of blood or cerebrospinal fluid.
- Formulate strategies to manage agitation, apathy, or problems with the inappropriate expression of sexuality in patients with dementia
- Discuss standards of care to optimize cognitive function through the use of cholinesterase inhibitors, memantine, and psychotropic medications in patients with dementia.
- Diagnose, work up and treat normal pressure hydrocephalus, as well as general medical co-morbidities in patients with dementia

Talks

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.